Tower Research Capital (TRC)’s RxSight RXST Stock Holding History
Bought
Maintained
Sold
Other funds holding RXST
NSGL
VCM
Tower Research Capital (TRC)'s RXST Position: Q1 2026 in Review
Tower Research Capital (TRC) reduced its RxSight (RXST) stake by 19% in Q1 2026, selling an estimated $8.4K and leaving 4,197 shares worth $25.9K. The position accounts for ﹤0.01% of the portfolio, ranked #3298.
Tower Research Capital (TRC) first reported a position in RXST in Q3 2021 and has held it in 19 quarters since. The position peaked at $317K in Q2 2024. 164 funds tracked by Wall St. Rank hold RXST as of Q1 2026.
- Tower Research Capital (TRC) held 4,197 shares of RxSight worth $25.9K as of Q1 2026.
- Tower Research Capital (TRC) sold 1,012 RxSight shares in Q1 2026, an estimated $8.4K.
- RxSight made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #3298 holding.
- Tower Research Capital (TRC) first reported a position in RxSight in Q3 2021 and has held it in 19 quarters since.
- Tower Research Capital (TRC)'s RxSight position peaked at $317K in Q2 2024.
- 164 funds tracked by Wall St. Rank held RxSight as of Q1 2026.
Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.